Low testosterone may possibly increase the risk of developing prostate cancer whereas normal levels may have no relationship to the risk of developing prostate cancer

Researchers from the Department of Urology, Graduate School of Medicine at Chiba University note that androgens are essential for prostatic development. They also state that the traditional view that a higher level of testosterone is a risk factor for developing prostate cancer has little evidence to support it. Some studies have actually shown a relationship between lower levels of testosterone and more advanced and more dangerous prostate cancer. Serum androgen levels within a broad range art suggested not to be related with prostate cancer risk. However, DHT or dihydrotestosterone is driveled from testosterone through the actions of type 1 and type 2 5Alpa-reductase and therapeutic results may be achieved through the suppression of 5alpha-reductase. The study is published in the September 2009 issue of the journal Future Oncology.